3rd Annual Oncology Market Access USA

Getting the most out of First-in-Human and Early Clinical Trials
In a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
The Clinical Pharmacology Regulatory Environment in the US, EU and Switzerland: Advantages and Disadvantages
Our expert panel with hands-on experience with the global development of new chemical enti
Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine Act
Beginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
Special Studies in Cancer Patients: AME and Cardiac Safety
FierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c

Tools

Location:

Boston

Date:

Feb 14-15 2012

For the first time every stakeholder in Oncology will come together to guide your access strategy. Key speakers include: Michael Sherman, CMO, Harvard Pilgrim, Marc Watrous, VP, Genentech , Anthony Davino, VP, Armada Healthcare. Get the full program HERE Save $200 and register now! Contact: tdisley@eyeforpharma.com

Share & Save

Digg
Reddit

Most Popular Stories

Webinars

Featured Jobs

Events

Free Newsletter

Popular Topics

Whitepapers

3rd Annual Oncology Market Access USA

THE FIERCEMARKETS NETWORK